RIGL

NASDAQ · Biotechnology

Rigel Pharmaceuticals Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$51.29

+2.43 (+4.97%)

RIGL News1 articles

Pfizer Shares Edge Up as Rigel Completes Veppanu Licensing Deal

Pfizer shares edged up after Rigel completed a Veppanu licensing deal with Arvinas, providing a $35 million payment to Pfizer.

Earnings Jun 16